Home News

Financial Results Nine month period 2019 - Video

Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the first nine months of 2019.

Mon, 25/11/2019 - 11:12 0 min
Download related document
No votes yet
 
Related
ROVI announces a collaboration with Roche for the manufacture of a new medicine...
  Madrid, Spain –21 October 2025. Today, Laboratorios Farmacéuticos Rovi, S.A. (hereinafter, “ROVI”), a pan-European pharmaceutical...
3 min
21/10/2025
ROVI announces the acquisition of an injectable drug product manufacturing site...
Laboratorios Farmacéuticos Rovi, S.A. announces that ROIS Phoenix Inc. (the “Buyer”), a wholly owned subsidiary of ROVI Pharma Industrial...
1 min
29/09/2025
First half 2025 results press release
​Operating revenue in the first half of 2025 was 314.6 million euros, a 4% decrease on the first half of 2024, mainly due to the...
3 min
24/07/2025